Weight loss medication for teens after leukemia or lymphoma
This trial tests a combination pill (phentermine and topiramate) to help teens and young adults who are overweight after finishing cancer treatment. The goal is to improve metabolic health and manage weight in remission.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated for leukemia or lymphoma and are currently in remission (no signs of cancer).
- You are between 12 and 24 years old.
- Your body mass index (BMI) is at or above the 95th percentile for your age and sex, or your BMI is at least 30.
- You have finished all chemotherapy that includes steroids, and you are either still on maintenance therapy (no more inpatient stays) or finished treatment up to about 27 months ago.
- You are not currently taking any weight-loss medications (like semaglutide or similar) and have not used them in the past 3 months.
- You must not be pregnant or planning to become pregnant, and if you are sexually active, you must use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different smartphone-based programs to help young adult cancer survivors lose weight. Participants are randomly assigned to one of two programs and use an app to track their progress.
This trial tests if combining resistance exercise with the weight-loss medication tirzepatide can improve heart and metabolic health in survivors of childhood acute lymphoblastic leukemia (ALL) who are now adults and have obesity or overweight with related health issues. You may benefit if you finished treatment at least 2 years ago and meet weight and health criteria.
This study tests a combination of two medications, phentermine and topiramate, to see if they help young people with hypothalamic obesity lose weight safely. Hypothalamic obesity is rapid weight gain caused by injury to the hypothalamus, often from a brain tumor or its treatment.
This study tests a medicine called phentermine to help teens ages 12 to 17 with obesity lose weight. It will check if the medicine is safe and works well for teenagers.
This study looks at how to help children and teens who had leukemia manage their weight after treatment ends. It involves family support and exercise.
This trial tests a bilingual, online program to help children and teens who have ALL (a type of leukemia) stay at a healthy weight during the maintenance phase of treatment. It may help lower the chance of gaining too much weight while on chemotherapy.
Hear when a new Acute Lymphoblastic Leukemia in Remission trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.